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In rural areas of South and Southeast Asia malaria is declining but 
febrile illnesses still account for substantial morbidity and mortality. 
Village health workers (VHWs) are often the first point of contact with 
the formal health system, and for patients with febrile illnesses they 
can provide early diagnosis and treatment of malaria. However, for 
the majority of febrile patients, VHWs lack the training, support and 
resources to provide further care. Consequently, treatable bacterial 
illnesses are missed, antibiotics are overused and poorly targeted, and 
patient attendance wanes along with declining malaria. 
This Open Letter announces the start of a new initiative, the Rural 
Febrile Illness (RFI) project, the first in a series of projects to be 
implemented as part of the South and Southeast Asian Community-
based Trials Network (SEACTN) research programme. This multi-
country, multi-site project will begin in Bangladesh, Cambodia, Lao 
PDR, and Myanmar and will define the epidemiological baseline of 
febrile illness in five remote and underserved areas of Asia where 
malaria endemicity is declining and access to health services is limited. 
The RFI project aims to determine the incidence, causes and outcomes 
of febrile illness; understand the opportunities, barriers and appetite 
for adjustment of the role of VHWs to include management of non-
malarial febrile illnesses; and establish a network of community 
healthcare providers and facilities capable of implementing 
interventions designed to triage, diagnose and treat patients 
presenting with febrile illnesses within these communities in the 
future.
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Introduction
The majority of individuals in South and Southeast Asia live in 
rural areas, often characterised by high levels of poverty and 
restricted access to healthcare1–3. Data on causes of disease in 
these areas to prioritise interventions for scale up are limited. 
Despite this, there are indications that diseases of an infectious 
aetiology, ‘febrile illnesses’, account for substantial morbidity 
and mortality4,5.
Malaria is the quintessential febrile illness. For decades, 
empiric antimalarials were recommended for patients present-
ing with fever6, reflective of the burden associated with this 
fatal but treatable illness. In many parts of Asia, village health 
workers (VHWs) were introduced to improve access to treat-
ment. Rapid declines in malaria incidence have subsequently 
been observed7. As a result, today fever seldom means malaria8, 
and the exact cause of the illness often remains unknown, 
as does optimal management and what becomes of these 
individuals9.
Falling malaria incidence highlights the inadequacies and 
fragilities of this vertical approach to healthcare. VHWs receive 
limited training, support and remuneration, and once malaria 
has been ruled out, often cannot provide further testing or 
treatment for their patients. Consequently, treatable bacterial 
infections are missed10,11, and antibiotics, if available, are 
overused and poorly targeted11–13. Furthermore, the current 
inability to address non-malarial fever adversely affects uptake of 
malaria testing: patients have little to gain from having malaria 
ruled out in areas where it is already rare, but no other care 
offered for their illness14,15. This hampers eradication efforts and 
risks resurgence of drug-resistant malaria16,17. Encouragingly, 
it has been shown that the trend of decreasing patient attend-
ance (and malaria testing) can be reversed when the remit of 
the VHW is extended to other basic healthcare provision14.
This Open Letter announces the start of the Rural Febrile 
Illness (RFI) project, the first project in the South and 
Southeast Asian Community-based Trials Network (SEACTN) 
research programme18. The RFI project will begin in Bangladesh, 
Cambodia, Lao PDR and Myanmar and aims to define the 
epidemiological baseline of febrile illness in remote and under-
served areas of Asia where malaria endemicity has declined and 
access to health services is limited. The primary objective of 
the RFI project is to determine the incidence, causes and out-
comes of febrile illness in the rural communities residing within 
the project areas. The longer-term objective of SEACTN is to 
establish a network of community healthcare providers and 
facilities, capable of implementing interventions designed to 
triage, diagnose and treat patients presenting with febrile ill-
nesses and other causes of ill health within these communities 
in the future.
Project overview
The RFI project is a multi-country, multi-site initiative 
comprised of a number of prospective observational studies. 
The project is divided into three key Work Packages (WP) 
with parallel supporting activities (Table 1). Detailed protocols 
for individual components of the RFI project are available 
at www.seactn.org.
Work Package A (WP-A)
In collaboration with VHWs we will develop and deploy 
electronic data collection tools to capture the incidence, pre-
senting syndromes and outcomes of febrile illness amongst 
individuals presenting to the most peripheral level of the 
health system. In Lao PDR, community healthcare providers 
working at primary health centres (PHCs) rather than VHWs 
will implement the project, as utilisation of VHWs is currently 
low in this area2.
Data collected from VHWs and PHCs will be complemented 
by parallel health status and health seeking behaviour 
surveys, verbal autopsies, and village and health facility 
mapping projects, designed to gain a comprehensive under-
standing of the burden of febrile illness and access to care in 
the areas served by these health facilities and providers. We will 
also perform targeted aetiological investigations in a subset of 
patients presenting to WP-A providers and facilities.
Work Package B (WP-B)
WP-B activities will be concentrated around two higher-level 
health facilities (health clinics and/or hospitals) in each of 
the sites in Bangladesh, Laos PDR and Myanmar, located within 
(or nearby) the same geographical area as the VHWs and PHCs 
selected for WP-A. More extensive aetiological investiga-
tions, as well as assays of host biomarkers, will be performed 
in patients with febrile illnesses attending these facilities.
Work Package C (WP-C)
In WP-C we will draw on the data collected in WP-A and 
WP-B to create temporally- and spatially-explicit electronic 
decision-support tools (eDSTs), designed to assist community 
health workers (both VHWs and healthcare providers at PHCs) 
in their assessment, triage and treatment of patients presenting 
with febrile illnesses in rural and remote areas. The data from 
WP-A and WP-B will also be used to identify the most 
high-impact and cost-effective point-of-care tests (POCTs) 
that could be included within the eDSTs, as well as appropri-
ate delivery mechanisms. Subsequent deployment and health 
system integration will be informed by stakeholder analy-
ses in the same settings to better understand the opportunities, 
barriers and appetite for adjustment of the role of VHWs and 
other community healthcare providers to include management 
of non-malarial causes of febrile illness.
Study sites and implementing partners
Strong, long-standing partnerships have been leveraged to plan 
and implement this multi-disciplinary project, across at least 
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620 villages in five rural regions of Bangladesh, Cambodia, 
Lao PDR and Myanmar (Figure 1).
In Bangladesh the project will be implemented in partner-
ship with BRAC, one of the largest non-governmental devel-
opment organisations in the world. As of September 2020, 
130 villages have been selected and local health facilities 
(Upazila Health Complexes and District Hospitals) identified 
in Cox’s Bazar and Bandarban districts.
The project in Cambodia will be a collaboration with the 
National Center for Parasitology, Entomology and Malaria 
Control (CNM), the Provincial Health Departments of 
Battambang and Pailin provinces, and Action for Health 
Development (AHEAD), a civil society organisation working 
to improve health in rural communities. The study will take 
place in western Cambodia in 120 villages from Pailin and 
Battambang provinces.
Two study sites are planned in Myanmar. In Northern Kachin 
state, 89 villages and two health clinics (Himalaya Clinic I 
and II), have been selected across three townships (Puta-O, 
Machanbaw and Nawngmun), where Medical Action 
Myanmar (MAM), a non-governmental healthcare organisation, 
operates a network of VHWs and rural health clinics. The second 
site is in Kayin state, where the Shoklo Malaria Research 
Unit (SMRU) supervises a large community health worker pro-
gramme focused on malaria elimination. Overall, 130 villages 
and two health clinics (Wang Pha and Mawker Thai) across 
the townships of Hlaingbwe, Myawaddy and Kawkareik are 
planned for selection.
In southern Lao PDR, 28 PHCs (serving 160 villages) within 
three districts (Atsaphangthong, Thaphalanxay and Phin), 
as well as Atsaphangthong district hospital and Savannakhet 
provincial hospital have been selected. The project will be 
conducted in partnership with Savannakhet Provincial Health 
Office (SPHO).
Table 1. Key objectives of the RFI project.
Overall
1 Determine the incidence, causes and outcomes of febrile illness in five rural areas of Bangladesh, Cambodia, Lao PDR and Myanmar
2 Establish a network of community healthcare providers and facilities, capable of implementing interventions designed to triage, diagnose and treat patients presenting with febrile illnesses within these communities in the future
Work Package A
1 Develop electronic data collection tools for patients presenting to village health workers and primary health centres with febrile illnesses in the study areas
2 Determine the incidence and outcomes of febrile illnesses amongst patients presenting to village health workers and primary health centres in the study areas
3 Describe and understand health status and health-seeking behaviour for febrile illnesses in the study areas
4 Describe common causes of mortality and events immediately preceding death in the study areas
5 Map the geographic location, accessibility, treatment availability and workforce capacity of health facilities within and nearby the study areas 
Work Package B
1 Describe the causes and outcomes of febrile illnesses amongst patients presenting to sentinel rural health facilities in the study areas
2 Determine the diagnostic performance of host biomarkers to distinguish bacterial from viral infections amongst patients presenting with febrile illnesses
3 Determine the prognostic performance of host biomarkers to identify patients with febrile illnesses at risk of severe outcomes
Work Package C
1 Complete stakeholder analyses to identify the opportunities, barriers and appetite for adjustment of the role of community healthcare providers to include management of non-malarial causes of febrile illness
2 Model the cost-effectiveness of different combinations of interventions to improve the management of febrile illness in the study areas
3 Develop and pilot electronic decision-support tools and point-of-care tests that can assist community healthcare providers in their assessment, triage and treatment of patients with febrile illnesses
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WP-A
Electronic data collection tools
Electronic data collection forms are being developed using the 
CommCare platform (Cambridge, MA, USA) and loaded on 
to mobile Android tablets. The tablets, accompanied by solar 
chargers where necessary, will be distributed to all VHWs 
(PHCs in Lao PDR) in SEACTN villages. Their feedback 
will inform iteration of the data collection forms following a 
human-centred design approach19. Once finalised, the tablets 
will be used to capture data from patients with febrile illnesses 
who attend the VHWs and PHCs (see below).
Data will be securely uploaded in real-time. In areas without 
mobile internet uploads will occur periodically during visits by 
the local implementing partner (BRAC, AHEAD, MAM, SMRU 
or SPHO). The aim is to develop a data stream from source to 
web-based interface with near real-time geospatial mapping 
of the incidence and outcomes of febrile illness. A detailed 
Data Management Plan is available on request from the 
Mahidol-Oxford Tropical Medicine Research Unit (MORU) 
Data Access Committee.
Digital health education materials
Training materials are being developed in partnership with 
DigitalMedic and serve three primary purposes:
•     To sensitise communities to the project aims and 
objectives (see below);
•     To support in-person training of the VHWs and PHC 
workers, focussing on ensuring accurate syndromic 
classification of febrile illnesses, reliable collection of 
clinical data and biological samples, and confidence in 
operating the electronic data collection tool;
•     To improve patient understanding of the health 
problems the project aims to address.
Community engagement activities
Prior to the initiation of the study the local implementing 
partner will meet with villagers, village leaders and relevant 
local authorities to explain the project rationale, aims and 
planned activities, using digital educational material as outlined 
Figure 1. Study areas with selected villages and health facilities. AHEAD, Action for Health Development; MAM, Medial Action Myanmar; 
SMRU, Shoklo Malaria Research Unit; SPHO, Savannakhet Provincial Health Office; WP-B, Work Package B. Due to access difficulties related 
to the ongoing COVID-19 pandemic, participating villages in the townships of Hlaingbwe and Kawkareik (Thai-Myanmar border region) and 
WP-B health facilities in Bangladesh are yet to be finalised. WP-B activities are currently not planned in Cambodia and village selection is 
underway.
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above. Community consent will be sought for the collection of 
basic demographic and syndromic data (using the same elec-
tronic data collection tool) from all patients attending VHWs 
and PHCs (both febrile and non-febrile patients) to better 
understand the health needs of the community and inform 
future directions of the SEACTN.
Determining the incidence and outcomes of febrile 
illnesses in patients presenting to village health 
workers and primary health centres
All patients who attend the VHW (or PHC in Lao PDR) will 
be screened, and those with a febrile illness who provide 
consent will be enrolled. Enrolment will be consecutive and 
is planned for 18 months. Based on current attendances we 
estimate that we will capture approximately 100,000 febrile 
illness episodes across the five study sites.
The VHW (or PHC worker) will use the electronic data col-
lection tool to record a limited set of clinical data and the result 
of the malaria rapid diagnostic test (mRDT). No changes to 
patient management will occur as a result of the study, except 
that the health worker will be prompted to consider referral 
and/or inform the operations team of the implementing part-
ner if any danger signs are elicited, subject to the specific 
context at each site20–22. The participant will be followed-up by 
the VHW 28 days later to determine the outcome of their illness.
In participants outside the neonatal age range a capillary blood 
sample (finger- or heel-prick) will be collected at the same time 
as the mRDT and stored as a dried blood spot (DBS) on filter 
paper. In a subset of participants (at least 20,000 illness 
episodes) a convalescent DBS will be collected at the one-month 
follow-up. Targeted molecular and serological investigations 
(Table 2) will be performed on an initial set of 10,000 illness 
Table 2. Aetiological investigations to be performed in the RFI project, including specimen type, target pathogen, 
diagnostic platform and laboratory location24–26. *Dengue NS1 testing will be performed on the acute (D0) sample only. 
**Blood cultures will be performed in-country at a quality-assured laboratory close to the WP-B health facility. RDT, rapid 
diagnostic test; JE, Japanese Encephalitis; NPS, nasopharyngeal swab.
Setting Specimen Target pathogen










VHWs and PHCs Capillary blood
Plasmodium spp. RDT
Dengue ✓ NS1* and IgM
Chikungunya ✓ IgM
Pan-Alphavirus ✓








Capillary blood Plasmodium spp. RDT or microscopy
Venous blood
Dengue ✓ NS1* and IgM
Chikungunya ✓ IgM
Pan-Alphavirus ✓
Pan-Flavivirus ✓ Zika and JE IgM
Orientia tsutsugamushi ✓ IgM
Rickettsia spp. ✓ IgM
Leptospira spp. ✓ IgM
16S rRNA (eubacteria) ✓
Bacterial bloodstream infections Blood culture**
NPS Respiratory pathogens ✓
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episodes to determine the aetiology of the febrile illness, with 
remaining samples stored for future targeted analyses.
Health-seeking behaviour surveys
We will conduct health status and health-seeking behaviour 
surveys to understand pathways to care for individuals with 
febrile illnesses. A better appreciation of how care for acute 
illness is currently sought in these settings will enable us to 
determine the overall burden of febrile illness in the study areas, 
and identify the best options for potential intervention in the 
future.
Community-level data, such as estimated vaccine coverage, 
availability of water, sanitation and hygiene (WASH) facilities, 
and assessments of indoor air quality, will be gathered to help 
contextualise the project’s findings.
Verbal autopsies
Little information exists on the febrile (and non-febrile) causes 
of mortality in the study areas23. In collaboration with researchers 
from the University of Toronto, we have adapted the 
World Health Organization’s (WHO) Verbal Autopsy (VA) 
tool to conduct electronic VA questionnaires for all deaths that 
occur in SEACTN villages in Bangladesh, Cambodia, Lao PDR 
and the North Kachin site in Myanmar27. Understanding the 
common causes of mortality and the circumstances that sur-
round death will enable us to identify targets for interventions 
that can be implemented and evaluated within the SEACTN 
programme in the future.
Village and health facility mapping
A thorough understanding of local healthcare infrastructure 
is essential to direct referrals to higher-level care appropri-
ately. Villages, transport networks and health facilities in the 
study areas will be mapped using field collection and satel-
lite imagery, and detailed profiles created of the study villages 
including population statistics, communication and transport 
systems, health services and campaigns, physical environment 
and socioeconomic metrics. WHO’s AccessMod 5 software will 
be used to estimate travel time from the study villages to health 
facilities and potential gaps in local service provision identi-
fied. In addition to informing how future interventions can be 
deployed within the SEACTN, we will provide this infor-
mation to health system planners and policy makers to help 
identify where new health facilities could be provided and 
existing services strengthened to achieve highest impact.
WP-B
Determining the aetiologies of febrile illnesses in 
patients attending rural health facilities
To gain a comprehensive understanding of the causes of febrile 
illness in the region, we will recruit a cohort of patients 
attending two sentinel health facilities within four of the project 
areas. The information from these cohorts will be combined 
with the aetiological data from WP-A, where we are limited to 
collecting low-volume DBS specimens from a subset of par-
ticipants (the remote locations preclude collection of samples 
from all villages and prevent maintenance of a cold chain).
All patients aged > 28 days who attend the health facilities with 
a febrile illness will be screened, and those who provide con-
sent will be enrolled. Six hundred participants (inpatients and 
outpatients) will be enrolled in each age stratum (> 28 days to 
< 5 years; ≥ 5 years to < 15 years; ≥ 15 years), across both 
health facilities within a single project area (i.e. 1,800 par-
ticipants in each area). Recruitment is planned for a minimum 
12 continuous months at each site to ensure seasonality is 
adequately captured.
Baseline data will be recorded including demographics, anthro-
pometrics, presenting syndrome, vital signs, clinical signs, 
duration of illness and any care sought for the illness thus far. 
In Bangladesh, Lao PDR and the Kayin state site in Myanmar 
blood cultures will be collected and the results provided to 
the treating clinical teams.
Venous blood samples and nasopharyngeal swabs will be 
collected and transported to MORU’s central laboratories 
in Bangkok, where molecular and serological aetiological 
investigations (Table 2) will be performed. Novel molecular 
techniques such as target enrichment sequencing will also be 
validated against existing molecular diagnostics and used to 
investigate a broader range of pathogens than can be detected by 
the pathogen-specific tests28. Additional investigations for par-
ticipants with specific syndromes (for example, urine, pus, throat 
swab and/or cerebrospinal fluid culture) will be considered, 
subject to feasibility at each of the facilities.
Admitted participants will be followed-up daily during their 
admission. All participants will be followed-up on day 2 (in per-
son or via telephone) and asked to return to the health facility 
28 days after enrolment to determine the outcome of their 
illness. A venous blood sample will be collected at this time 
for convalescent serological testing.
Identification of clinical features and host biomarkers 
that distinguish bacterial from viral infections in febrile 
patients
The venous blood samples collected from patients attending 
the rural health facilities will also be used to quantitatively 
measure host biomarkers that reflect immune activation and 
endothelial dysfunction. We will use this information, together 
with the baseline clinical data and results of the aetiological 
investigations, to construct diagnostic algorithms that can 
distinguish bacterial from viral infections29–32. Host biomarkers 
feasible for measurement using POCTs, will be prioritised, 
so that the algorithms could be used to guide antimicrobial 
prescribing in resource-limited primary care settings.
Development of prognostic clinical prediction models 
for febrile patients at risk of severe outcomes
We will also use the host biomarker data, in conjunction with 
the baseline clinical and day 2 and 28 outcome data, to derive 
prognostic algorithms (clinical prediction models) to identify 
patients at risk of severe outcomes, which could be used to 
guide referral decisions from community healthcare settings to 
higher-level care33–38. The baseline clinical data, host biomarker 
panels and outcome definitions have been harmonised with a 
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parallel study (NCT04285021) to facilitate data sharing and 
external validation of the prediction models.
WP-C
Stakeholder mapping and analyses
Throughout the RFI project, key stakeholders will be engaged 
and interviewed on the topic of expanding the remit of VHWs 
and/or other community healthcare providers to include manage-
ment of non-malarial febrile illnesses. Stakeholders will include 
policy makers and managers within the Ministries of Health 
of the respective countries; representatives of international and 
national donor organisations; individuals and organisations 
responsible for the implementation and supervision of VHW 
and other community-based health programmes; and VHWs and 
community members.
During the interviews, information and views will be 
collected about operational challenges, opportunities and policy 
bottlenecks concerning the expansion of VHW programmes, 
with particular attention to the key issues of health system 
integration, capacity, and sustainability. After an initial set of 
interviews with seed informants, selected after a stakeholder 
mapping exercise, additional interviewees will be identified 
through snowball sampling. Collected material will be analysed 
thematically, while interim outputs such as matrix tables or posi-
tion maps will be constructed to better understand the role and 
interest of different categories of stakeholders, their resources, 
and their level of support to the expansion of VHW programmes. 
Findings will also inform participatory development of the 
eDSTs (see below).
Economic evaluation of interventions that could be 
deployed in the SEACTN to improve the management of 
febrile illness
We will draw on the data and findings from WP-A and WP-B 
to develop economic models to assess the cost-effectiveness of 
different (combinations of) interventions to improve the man-
agement of febrile illness, that could be trialled in subsequent 
projects within the SEACTN. Analyses will be conducted on 
standalone interventions such as the implementation of POCTs39, 
as well as multi-layered approaches integrating regional data 
on causes of illness within eDSTs, alongside POCTs40. The out-
puts of the cost-effectiveness analyses will also be provided to 
relevant governmental and non-governmental actors to support 
the planning and scale-up of national programmes.
Development of eDSTs for use by rural community 
healthcare providers
The results from these modelling assessments and the data from 
WP-A and WP-B, will be used to design bespoke, spatially-
explicit eDSTs that can assist community healthcare providers 
in their assessment, triage and treatment of patients with febrile 
illnesses (Figure 2).
Figure 2. Overview of the long-term ambition for the management of febrile illnesses within SEACTN. (1) Patient with febrile 
illness presents to village health worker (VHW). (2) Simple clinical algorithm pre-loaded on mobile device helps VHW assess patient. 
(3) VHW performs point-of-care test (POCT) if recommended by algorithm. (4) VHW decides between community-based treatment or 
referral for higher-level care. (5) Regional health facilities (sentinel nodes) periodically provide data from patients attending with febrile 
illnesses (including patients referred by VHWs working within SEACTN). (6) Proportion of samples collected from febrile patients at the time 
POCTs are performed, stored on filter paper and transported to reference laboratories. (7) Data from (5) and (6) integrated with data from 
(2) to periodically update clinical algorithms to reflect seasonal and longitudinal changes in febrile illness landscape.
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The eDSTs will be loaded on to the mobile tablets that the 
VHWs and PHC workers are already familiar with using for 
data collection. Interactive training modules will be developed 
(in partnership with DigitalMedic), and will include educational 
content on the common causes of febrile illness in the region, as 
well as instructional information on how to use the new eDSTs 
and any relevant POCTs. User feedback will be sought and the 
eDSTs iterated using a human-centred design process19. Once 
finalised the eDSTs will be put forward for evaluation in 
future projects to be conducted within the SEACTN.
Dissemination of findings
Interim findings from relevant aspects of the project (for 
example, aggregate results of the aetiological investigations for 
febrile illness and the VA study) will be periodically summarised 
and fed back to the local communities via village leaders and 
local authorities. This will allow important information to 
be actioned in a time-sensitive manner, whilst preserving the 
confidentiality of individual participants.
The final results generated from this study will be disseminated 
to key stakeholders (identified during the stakeholder mapping 
exercises) and the study communities (via the same community 
engagement forums used to launch the project) in both 
English and local languages. The results will also be shared 
with the scientific community via peer-reviewed publications 
and conference presentations.
Limitations
Studying febrile illness at the most peripheral level of a 
health system provides a unique opportunity to influence the 
course of a patient’s illness at their first contact with formal 
health services. This is particularly important in settings 
where regulation of facilities, providers and treatments is often 
lacking or inadequately enforced. However, working at this 
level of the health system also poses certain challenges.
We are limited to collecting low-volume DBS specimens 
from patients attending VHWs and PHC workers. The aetio-
logical yield of these specimens may be low. However, they are 
feasible for collection in large numbers, and without attempts 
to understand the causes of fever in rural areas of the region, 
meaningful improvements in the management of febrile illness 
will likely remain elusive. To mitigate this risk, we will recruit 
cohorts of patients attending sentinel health facilities within 
these areas (WP-B), where collection of a wider range of 
specimens will permit more extensive aetiological investiga-
tions. Furthermore, the yield from the DBS specimens will be 
monitored and reviewed by the RFI Study Management Group. 
Depending on the results, DBS assaying may be expanded 
or replaced with an alternate strategy.
Expansion of the role of VHWs is both feasible and impactful14. 
However there is a limit to the number of roles that these skilled 
yet lay-people can be expected to fulfil, without adequate rec-
ognition, supervision and remuneration41. Stakeholder engage-
ment, planned throughout the RFI project, will be crucial to 
understand the feasibility of long-term adjustments to the 
VHW role.
Conclusion
The RFI project aims to better understand and quantify the bur-
den of febrile illness, the aetiological causes and the manner in 
which it affects people living in some of the most underserved 
areas of South and Southeast Asia, all on a scale which has not 
been attempted before. We will collect information to better 
understand and predict the outcomes of patients with febrile 
illnesses based on a multitude of factors, which will form 
the basis for interventions within the SEACTN in the future.
The foundational infrastructure established by the RFI project 
will include a network of upskilled and supported community 
healthcare providers, user-friendly electronic data collection 
tools, functioning biological specimen collection, transport and 
diagnostic pipelines, and robust data management systems for 
near real-time geospatial mapping of the incidence and out-
comes of patients with febrile illness. SEACTN will be well 
positioned to support ongoing surveillance of febrile illnesses 
in the region, enabling earlier detection of disease outbreaks 
and the regular updating of treatment algorithms in response 
to seasonal and longitudinal changes in the regional febrile 
illness landscape.
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This open letter describes plans for a large, multi-country project focused on describing the 
etiology and improving the management of febrile illness in rural areas of South and Southeast 
Asia. This ambitious work is incredibly important as the widespread availability of malaria testing 
and treatment has led to a decline in malaria incidence, leaving most febrile illnesses 
undifferentiated. This diagnostic uncertainty leads to inappropriate and inadequate treatment, 
including the overuse of antibiotics, which drives antimicrobial resistance, a major threat to global 
public health. 
 
In this article, the authors clearly outline their objectives and plans for implementation of the 
initiative, and the maps in Figure 1 distinctly show the varied locations of the included study sites. I 
also appreciated their acknowledgment of the challenges of working in rural areas with VHW 
providers, and think that there was sufficient explanation and justification of their plans. The 
continual reassessment of the feasibility of expanding the VHW role through stakeholder 
engagement itself will provide interesting information that will shape the evolution of such 
programs in response to the changing epidemiology of the conditions that VHW treat. 
 
A few minor comments related to each Work Package are as follows: 
 
WP-A
Please clarify the patient population that will be included. As the VHWs will be the primary 
providers that are included in the study, I assume the patient population will be children 
under 5 years of age, but would recommend clearly stating the target study population and 
if there are any differences in the age groups that will be enrolled at each site. 
 
1. 
How will follow-up assessments be done? In other words, will they be in-person visits or 
phone calls? I assume in-person for at least a portion as convalescent DBS are being 
collected, but some clarification here would be useful. 
2. 
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How was 28 days chosen for the follow-up interval? This seems to be quite long for acute 
febrile illnesses. A brief justification of how this interval was chosen would be helpful. 
 
3. 
Will the health-seeking behaviour surveys be conducted for all participants in WP-A or a 




Again, a bit more clarification about age group would be helpful here - will any adults be 
enrolled or does the >/= 15 age group only extend up to 18 years of age? 
 
1. 
Would be interested in more detail regarding the host biomarker testing. Specifically, which 




I found Figure 2 to be a bit confusing, particularly the group of icons in the center. Perhaps 
it would be helpful to include a few more arrows demonstrating the progression of the 




A few stylistic/grammatical things to consider are as follows:
Could delete word "residing" in last paragraph of the introduction as communities 
themselves don't res 
 
○




Should be "local facilities have been identified" in same paragraph 
 
○
Remove the parentheses around "combinations of" in the paragraph about economic 
evaluation of interventions in WP-C section.
○
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Overall, a clear, well-written letter. This is an important topic and the proposed initiative has the 
potential to positively impact child health. 
 






Suggest describing village health workers some more. For example, who are they, what role 
do they play, how do they improve access to treatment... 
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What is the proposed timeline for this project and the various work packages?○
 
Study sites and implementing partners
Was there a site selection process and if so, what was it? Was there an effort to recruit a 
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The open letter communicates about a series of planned studies in several study sites in Asia to 
define aetiology of febrile illnesses, develop and implement point of care tests (POCTs) to 
differentiate bacterial versus viral infections, develop electronic decision support (eDST), and 
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implement the POCTs and eDSTs using community health workers (village health workers and 
primary health care workers) for referral and treatment. In this letter, the authors have 
summarised linked pieces of research projects that are grouped into 3 work packages with several 
specific objectives. It is therefore expected that sufficient detail would be missing in a project that 
has several components. However, the ultimate success of this project as described would a 




A brief description of training and capabilities of CHWs in the study settings will assist readers to 
gain insights into prospects of successful implementation. What other tasks do the CHWs already 
have? Will therefore be detailed implementation science conducted to understand implementation 
challenges for the project and is there a conceptual framework for the project implementation? It 
would be good to briefly mention how the implementation is expected to work at the level of 
CHWs who are quite central. Are the CHWs remunerated, what is their motivation, how much are 
researchers working with policy makers in the study countries-some insights will be good. Are the 
village health workers collecting heel/thumb prick samples? Is this something that they are 
permitted to do in this setting-this could be briefly explained.    
 
Are there examples of treatments that CHWs would be allowed to give based on results of POCTs? 
If POCTs suggests a bacterial infection, it may be harmful to give an antibiotic and send the 
patient home since causes of a positive bacterial test could be varied e.g., UTI, sepsis, intra-
abdominal infections (especially in adults), and it is difficult to imagine an antibiotic that can be 
given by CHWs that would cover all potential causes without need for a referral. In such cases, 
eDST would be configured to trigger a referral or no referral. 
 
It would seem more logical if aetiological study and development of POCTs were done at earlier 
phases and then promising POCTs implemented plus eDST using CHWs. Can a diagram for 
sequence of activities be included?;
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